The Asian Consortium on MRI studies in Psychosis (ACMP) is the first Asian international multi-center clinical neuroimaging study in psychiatry launched 2017. There are several strengths of the ACMP such as mostly Asian ethnicity, similar clinical and social backgrounds, expected larger sample size, little effect of illegal drug use, and a closer relationship between research and clinical departments. ACMP can provide novel findings for identifying biological basis of schizophrenia and finding the candidates for clinical applications in bed side.

Fig. Overview of the ACMP MRI and clinical dataset pipeline.